Julie H Hoover-Fong

Dr. Julie H Hoover-Fong


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2021 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
PDF file
RSRavi Savarirayan
Ravi Savarirayan
PIPenny Ireland
Penny Ireland
MIMelita Irving
Melita Irving
DTDominic Thompson
Dominic Thompson
Ines AlvesInes Alves
Ines Alves
SFSvein Otto Fredwall
Svein Otto Fredwall

1 June 2020 in Pediatrics
Verified
Journal Article
Open access
PDF file
JHJulie H Hoover-Fong
Julie H Hoover-Fong
CSCharles I. Scott
Charles I. Scott
MJMarilyn C. Jones
Marilyn C. Jones
CGCOMMITTEE ON GENETICS
COMMITTEE ON GENETICS
ECEmily Chen
Emily Chen
JSJoan M. Stoler
Joan M. Stoler
Achondroplasia is the most common short-stature skeletal dysplasia, additionally marked by rhizomelia, macrocephaly, midface hypoplasia, and normal cognition. Potential medical complications associated with achondroplasia include lower extremity long bone bowing, middle-ear dysfunction, obstructive sleep apnea, and, more rarely, cervicomedullary compression, hydrocephalus, thoracolumbar kyphosis, and central sleep apnea. This is the second revision to the original 1995 health supervision guidance from the American Academy of Pediatrics for caring for patients with achondroplasia. Although many of the previously published recommendations remain appropriate for contemporary medical care, this document highlights interval advancements in the clinical methods available to monitor for complications associated with achondroplasia. This document is intended to provide guidance for health care providers to help identify individual patients at high risk of developing serious sequelae and to enable intervention before complications develop.

1 May 2021 in Bone
Verified
Journal Article
Open access
JHJulie H Hoover-Fong
Julie H Hoover-Fong
MCMoira S. Cheung
Moira S. Cheung
VFVirginia Fano
Virginia Fano
LHLars Hagenas
Lars Hagenas
JHJacqueline T. Hecht
Jacqueline T. Hecht
RSRavi Savarirayan
Ravi Savarirayan
Achondroplasia, the most common form of disproportionate short stature, is caused by a variant in the fibroblast growth factor receptor 3 (FGFR3) gene. Advances in drug treatment for achondroplasia have underscored the need to better understand the natural history of this condition. This article provides a critical review and discussion of the natural history of achondroplasia based on current literature evidence and the perspectives of clinicians with extensive knowledge and practical experience in managing individuals with this diagnosis. This review draws evidence from recent and ongoing longitudinal natural history studies, supplemented with relevant cross-sectional studies where longitudinal research is lacking, to summarize the current knowledge on the nature, incidence, chronology, and interrelationships of achondroplasia-related comorbidities across the lifespan. When possible, data related to adults are presented separately from data specific to children and adolescents. Gaps in knowledge regarding clinical care are identified and areas for future research are recommended and discussed.

1 August 2008 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
JHJulie H Hoover-Fong
Julie H Hoover-Fong
KSKerry J Schulze
Kerry J Schulze
JMJohn McGready
John McGready
HBHillary Barnes
Hillary Barnes
CSCharles I Scott
Charles I Scott
Background: Achondroplasia is the most common short stature skeletal dysplasia, with an estimated worldwide prevalence of 250 000. Body mass index (BMI)–for-age references are required for weight management guidance for children with achondroplasia, whose body proportions are unlike those of the average stature population. Objective: This study used weight and height data in a clinical setting to derive smoothed BMI-for-age percentile curves for children with achondroplasia and explored the relation of BMI with its components, weight and height. Design: This was a longitudinal observational study of anthropometric measures of children with achondroplasia from birth through 16 y of age. Results: The analysis included 1807 BMI data points from 280 children (155 boys, 125 girls) with achondroplasia. As compared with the BMI of peers of average stature, the BMI in children with achondroplasia is higher at birth, lacks a steep increase in infancy and a later nadir between 1 and 2 y of age, and remains substantially higher through 16 y of age in both sexes. Patterns of change in height and weight in children with achondroplasia are unique in that there is no overlap in the height distribution after 6 mo of age and no spike in height velocity during infancy or puberty—the 2 periods of greatest linear growth in individuals of average stature. Conclusions: Sex- and age-specific BMI curves are available for children with achondroplasia (birth to 16 y of age) for health surveillance and future research to determine associations with health outcomes (eg, cardiovascular disease, diabetes, and indication for and outcome of surgery).

23 December 2021 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
JHJulie H Hoover-Fong
Julie H Hoover-Fong
KSKerry J. Schulze
Kerry J. Schulze
AAAdekemi Y. Alade
Adekemi Y. Alade
MBMichael B. Bober
Michael B. Bober
EGEthan Gough
Ethan Gough
JMJohn McGready
John McGready
Background: Achondroplasia is the most common genetic skeletal disorder causing disproportionate short stature/dwarfism. Common additional features include spinal stenosis, midface retrusion, macrocephaly and a generalized spondylometaphyseal dysplasia which manifest as spinal cord compression, sleep disordered breathing, delayed motor skill acquisition and genu varus with musculoskeletal pain. To better understand the interactions and health outcomes of these potential complications, we embarked on a multi-center, natural history study entitled CLARITY (achondroplasia natural history study). One of the CLARITY objectives was to develop growth curves (length/height, weight, head circumference, weight-for-height) and corresponding reference tables of mean and standard deviations at 1 month increments from birth through 18 years for clinical use and research for achondroplasia patients.Methods: All available retrospective anthropometry data including length/height, weight and head circumference from achondroplasia patients were collected at 4 US skeletal dysplasia centers (Johns Hopkins University, AI DuPont Hospital for Children, McGovern Medical School University of Texas Health, University of Wisconsin School of Medicine and Public Health). Weight-for-age values beyond 3 SD above the mean were excluded from the weight-for-height and weight-for-age curves to create a stricter tool for weight assessment in this population.Results: Over 37,000 length/height, weight and head circumference measures from 1374 patients with achondroplasia from birth through 75 years of age were compiled in a REDCap database. Stature and weight data from birth through 18 years of age and head circumference from birth through 5 years of age were utilized to construct new length/height-for-age, weight-for-age, head circumference-for-age and weight-for-height curves.Conclusion: Achondroplasia-specific growth curves are essential for clinical care of growing infants and children with this condition. In an effort to provide prescriptive, rather than purely descriptive, references for weight in this population, extreme weight values were omitted from the weight-for-age and weight-for-height curves. This well-phenotyped cohort may be studied with other global achondroplasia populations (e.g. Europe, Argentina, Australia, Japan) to gain further insight into environmental or ethnic influences on growth.

1 January 2014 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
JHJulie H Hoover-Fong
Julie H Hoover-Fong
NSNara Sobreira
Nara Sobreira
JJJulie Jurgens
Julie Jurgens
PMPeggy Modaff
Peggy Modaff
CBCarrie Blout
Carrie Blout
RPRichard M. Pauli
Richard M. Pauli